180 related articles for article (PubMed ID: 32598892)
21. Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity.
Joussain C; Phé V; Even A; Chartier-Kastler E; Denys P
Eur J Phys Rehabil Med; 2017 Dec; 53(6):991-997. PubMed ID: 29072045
[TBL] [Abstract][Full Text] [Related]
22. Treating overactive bladder with percutaneous tibial nerve stimulation.
Shireman J; Gajarawala SN; Stanton A; McCrary M
JAAPA; 2021 Dec; 34(12):27-30. PubMed ID: 34813532
[TBL] [Abstract][Full Text] [Related]
23. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment?
Marcelissen T; Cornu JN; Antunes-Lopes T; Geavlete B; Delongchamps NB; Rashid T; Rieken M; Rahnama'i MS
Eur Urol Focus; 2018 Sep; 4(5):760-767. PubMed ID: 29807823
[TBL] [Abstract][Full Text] [Related]
24. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.
Chughtai B; Clemens JQ; Thomas D; Sun T; Ghomrawi H; Sedrakyan A
J Urol; 2020 Jan; 203(1):179-184. PubMed ID: 31347949
[TBL] [Abstract][Full Text] [Related]
25. The pharmacologic management of idiopathic overactive bladder in primary care.
Ellsworth PI
J Fam Pract; 2014 Feb; 63(2 Suppl):S38-45. PubMed ID: 24527484
[No Abstract] [Full Text] [Related]
26. The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
Chapple C; De Ridder D
BJU Int; 2009 Nov; 104(9):1188-90. PubMed ID: 19681899
[No Abstract] [Full Text] [Related]
27. Best treatment for overactive bladder if behavioral treatment and anticholinergics fail. Onabotulinumtoxina.
Doggweiler R
J Urol; 2011 Jun; 185(6):2023-4. PubMed ID: 21496846
[No Abstract] [Full Text] [Related]
28. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con.
Bales GT
J Urol; 2017 Sep; 198(3):500-501. PubMed ID: 28751016
[No Abstract] [Full Text] [Related]
29. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Pro.
Kraus SR
J Urol; 2017 Sep; 198(3):501-502. PubMed ID: 28751015
[No Abstract] [Full Text] [Related]
30. Management of overactive bladder syndrome.
Srikrishna S; Robinson D; Cardozo L; Vella M
Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
[TBL] [Abstract][Full Text] [Related]
31. Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?
Marcelissen T; Rashid T; Antunes Lopes T; Delongchamps NB; Geavlete B; Rieken M; Cornu JN; Rahnama'i MS;
Eur Urol Focus; 2019 Nov; 5(6):1112-1119. PubMed ID: 29625926
[TBL] [Abstract][Full Text] [Related]
32. Management of Overactive Bladder Symptoms After Radical Prostatectomy.
Peyronnet B; Brucker BM
Curr Urol Rep; 2018 Oct; 19(12):95. PubMed ID: 30306278
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie J; Wilson DI; Herbison GP; Wilson D
Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
[TBL] [Abstract][Full Text] [Related]
34. [Overactive bladder-which treatment when?].
Pannek J
Urologe A; 2017 Dec; 56(12):1532-1538. PubMed ID: 29043374
[TBL] [Abstract][Full Text] [Related]
35. Overactive bladder: treatment options in primary care medicine.
Sussman DO
J Am Osteopath Assoc; 2007 Sep; 107(9):379-85. PubMed ID: 17908830
[TBL] [Abstract][Full Text] [Related]
36. Update on the treatment of overactive bladder.
Dmochowski RR; Gomelsky A
Curr Opin Urol; 2011 Jul; 21(4):286-90. PubMed ID: 21499104
[TBL] [Abstract][Full Text] [Related]
37. Emerging drugs for overactive bladder.
Karmarkar R; Khullar V
Expert Opin Emerg Drugs; 2015; 20(4):613-24. PubMed ID: 26359223
[TBL] [Abstract][Full Text] [Related]
38. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
Rai BP; Cody JD; Alhasso A; Stewart L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003193. PubMed ID: 23235594
[TBL] [Abstract][Full Text] [Related]
39. [Not Available].
Perucchini D; Betschart C; Fink D; Scheiner DA
Praxis (Bern 1994); 2017 Jan; 106(1):37-44. PubMed ID: 28055318
[No Abstract] [Full Text] [Related]
40. Future directions in overactive bladder treatment: Personalized medicine can be applied?
Lee KS
Korean J Urol; 2015 Oct; 56(10):671-2. PubMed ID: 26495066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
